Hearing Supplement Improvement Claims Don't Echo Separate Ingredient Studies
This article is powered by The Rose Sheet
Executive Summary
National Advertising Division says Bel Marra Health's reliance on ingredient studies with dosage or usage that could not translate to the ingredients in the product failed to support its claims. “Without testing that the ingredients in the quantity found in Hearing Rescue have the claimed effect, the results from these studies cannot be used to support qualified claims that the same ingredients in the product reduce the damage caused by repeated noise exposure and improve hearing,” NAD said following a review from a challenge by the Council for Responsible Nutrition.
You may also be interested in...
Clarion Brands Argues NAD Turns Deaf Ear To Tinnitus Claims Review
Clarion Brands appeals NAD’s recommendations to discontinue a testimonial and other claims that convey the message its Lipo-Flavonoid Plus substantially reduces or eliminates tinnitus and the symptoms of Ménière’s disease.
SmartX “Brain Supplement” Firm Should Rethink Its Product Claims – NAD
Cerebral Success submitted studies that did not test SmartX products or similar formulas, but were limited to findings on separate ingredients. NAD also said even when using the disclaimer “designed to,” an advertiser must provide reasonable support a product will “deliver the touted benefits to consumers.”
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.